95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.46%
Positive revenue growth while FNV is negative. John Neff might see a notable competitive edge here.
15.06%
Gross profit growth above 1.5x FNV's 0.29%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
16.70%
Positive EBIT growth while FNV is negative. John Neff might see a substantial edge in operational management.
16.70%
Positive operating income growth while FNV is negative. John Neff might view this as a competitive edge in operations.
-306.84%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-306.67%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-306.67%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.14%
Share count expansion well above FNV's 0.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.16%
Diluted share reduction more than 1.5x FNV's 0.73%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-9.68%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
27.85%
OCF growth above 1.5x FNV's 8.88%. David Dodd would confirm a clear edge in underlying cash generation.
27.22%
FCF growth under 50% of FNV's 95.64%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
143.50%
10Y revenue/share CAGR 1.25-1.5x FNV's 112.11%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-32.40%
Negative 5Y CAGR while FNV stands at 12.80%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
44.73%
3Y revenue/share CAGR above 1.5x FNV's 14.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
141.95%
10Y OCF/share CAGR 1.25-1.5x FNV's 100.46%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-47.98%
Negative 5Y OCF/share CAGR while FNV is at 11.49%. Joel Greenblatt would question the firm’s operational model or cost structure.
46.92%
3Y OCF/share CAGR similar to FNV's 47.60%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-379.09%
Negative 10Y net income/share CAGR while FNV is at 52.46%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-162.02%
Negative 5Y net income/share CAGR while FNV is 201.16%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-321.70%
Negative 3Y CAGR while FNV is 2945.86%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
215.88%
10Y equity/share CAGR above 1.5x FNV's 76.90%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
26.24%
5Y equity/share CAGR above 1.5x FNV's 15.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.10%
3Y equity/share CAGR at 75-90% of FNV's 16.10%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
7.02%
5Y dividend/share CAGR at 50-75% of FNV's 10.76%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
62.84%
3Y dividend/share CAGR above 1.5x FNV's 15.67%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-45.82%
Firm’s AR is declining while FNV shows 1.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.25%
Negative asset growth while FNV invests at 0.92%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.45%
We have a declining book value while FNV shows 0.67%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-9.84%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.81%
We cut SG&A while FNV invests at 37.21%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.